| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Guohui Wang CEO | TWSE Exchange | TW0006609001 ISIN |
| China Country | 341 Employees | - Last Dividend | - Last Split | - IPO Date |
Shanghai HeartCare Medical Technology Corporation Limited is at the forefront of innovation in the field of neuro-interventional medical devices, focused on developing, manufacturing, and selling state-of-the-art products for the medical industry. Founded in 2016 and headquartered in Shanghai, the People's Republic of China, the company specializes in providing advanced solutions for the treatment and prevention of acute ischemic stroke, neurovascular stenosis, and hemorrhagic stroke. Through its dedication to research and development, Shanghai HeartCare Medical Technology Corporation Limited aims to improve patient outcomes and enhance the quality of life for those suffering from these critical conditions.
These devices are engineered for the removal of clots from blocked brain arteries to restore blood flow in patients experiencing an acute ischemic stroke. Their innovative design and technology make them an effective solution for emergency stroke treatment.
Shanghai HeartCare provides advanced solutions for the treatment of intracranial arterial stenosis, a condition that leads to narrowed brain arteries, utilizing cutting-edge devices designed to widen the arterial passageways and enhance blood flow, thereby reducing the risk of stroke.
The flow diverter device is aimed at treating patients with aneurysms by diverting blood flow away from the aneurysm sac, thus promoting aneurysm thrombosis while maintaining patency of the parent vessel. This minimizes the risk of rupture and subsequent hemorrhagic stroke.
These devices facilitate access to the vascular system for the purpose of performing diagnostic or therapeutic procedures, including the deployment of stents or removal of blockages, paramount for effective treatment of various neurovascular conditions.
Focused on combating neurovascular stenosis, the company offers a range of devices that alleviate this condition by widening narrow vascular passages in the brain, ensuring an unimpeded flow of blood, essential for the healthy functioning of brain tissues.
Shanghai HeartCare’s offerings in this category are designed to limit the damage caused by hemorrhagic strokes through innovative devices that prevent blood vessel rupture or manage its consequences, thereby saving lives and improving recovery outcomes.
The interventional access products provide medical professionals with the necessary tools to access areas of the body affected by neurovascular conditions, facilitating a wide range of interventions from diagnostics to treatment application, ensuring high precision and safety.